Issue navigation
Volume 2, Issue 3, July 2016
Editorials
News from EHJCVP
Stefan Agewall
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 2, Issue 3, July 2016, Page 141, https://doi.org/10.1093/ehjcvp/pvw010
Highlights from the 65th American College of Cardiology Annual Scientific Session (ACC 2016)
Manan Pareek and Deepak L. Bhatt
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 2, Issue 3, July 2016, Pages 142–144, https://doi.org/10.1093/ehjcvp/pvw012
Original Articles
Thrombosis and antithrombotic therapy
Impact of renal impairment on platelet reactivity and clinical outcomes during chronic dual antiplatelet therapy following coronary stenting
Long Zhe Guo and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 2, Issue 3, July 2016, Pages 145–151, https://doi.org/10.1093/ehjcvp/pvv052
Acute coronary syndromes
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries
Nicolas Danchin and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 2, Issue 3, July 2016, Pages 152–167, https://doi.org/10.1093/ehjcvp/pvw003
Arrhythmia/electrophysiology
Effects of digitalis on mortality in a large cohort of implantable cardioverter defibrillator recipients: results of a long-term follow-up study in 1020 patients
Julia W. Erath and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 2, Issue 3, July 2016, Pages 168–174, https://doi.org/10.1093/ehjcvp/pvw008
Reviews
Disease management
The current role and future prospects of D-dimer biomarker
Armaghan Y. Soomro and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 2, Issue 3, July 2016, Pages 175–184, https://doi.org/10.1093/ehjcvp/pvv039
Vascular medicine
Gliptins and their target dipeptidyl peptidase 4: implications for the treatment of vascular disease
Friederike Remm and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 2, Issue 3, July 2016, Pages 185–193, https://doi.org/10.1093/ehjcvp/pvv044
Coronary artery disease
Targeting T cells to treat atherosclerosis: odyssey from bench to bedside
Jessica Bullenkamp and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 2, Issue 3, July 2016, Pages 194–199, https://doi.org/10.1093/ehjcvp/pvw001
Obesity and metabolic syndrome
Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion
Faiez Zannad and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 2, Issue 3, July 2016, Pages 200–205, https://doi.org/10.1093/ehjcvp/pvw007
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals